Millions of Americans take statin drugs to help lower their cholesterol, making it one of the most popular classes of prescription drugs on the market today; but, like most prescription medications, these drugs are often unnecessary, as most Americans could lower their LDL (bad) cholesterol levels simply by changing their diet and lifestyle. However, we live in a world where people are looking for a quick fix, and doctors are eager to recommend "magic pills" to patients with any and all health concerns. The problem with these so-called "magic pills" is that they often end up doing more harm than good. Such is the case with Lipitor, the most popular of the five statin drugs available today.
In 2001, patients filled more than 57 million prescriptions for Lipitor, a drug that promises to reduce high levels of LDL (bad) cholesterol while increasing levels of HDL (good) cholesterol. Proponents of Lipitor and other statin drugs claim that they, in addition to normalizing cholesterol levels, can reduce inflammation and reduce the risk of heart attack, stroke and heart-related deaths in general. What doctors and pharmacists are less likely to explain in full to patients, however, are the potential side effects of drugs like Lipitor -- side effects that can outweigh any potential good the drugs might purport to do.
The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other uncensored news on important consumer health topics, can be found at:
Statin drugs expose patients to dangerous, debilitating side effects
http://www.newstarget.com/021397.html
About NewsTarget
Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.